
Small grants from Eurasian Harm Reduction Association
Resource assistance/funding is given for the advocacy activities that address human right violations during Covid-19 in CEECA region. Applications are accepted till February 24, 2021.

Resource assistance/funding is given for the advocacy activities that address human right violations during Covid-19 in CEECA region. Applications are accepted till February 24, 2021.

Within EU-funded COVID-19 Solidarity Programme for the Eastern Partnership countries AFEW International prepares bi-weekly updates on the COVID-19 developments in the

Representatives of AFEW International and AFEW Kyrgyzstan have contributed towards a rapid review of peer involvement of people who use drugs in HIV and harm reduction services in low- and middle-income countries.

Our Supervisory Board Chairman Prof Michel Kazatchkine has been awarded the Desmond Tutu award for HIV prevention research and human rights at the HIVR4P conference!

Within EU-funded COVID-19 Solidarity Programme for the Eastern Partnership countries AFEW International prepares bi-weekly updates on the COVID-19

Please, share with us your last updates and help us to improve our monthly newsletter!

WHO Regional Office for Europe is calling for submissions of good practices on response to TB HIV and Hep during the COVID19 pandemic.

In 2020, the Emergency Support Fund for key populations in Eastern Europe and Central Asia supported 85 applications from 9 countries. One of them was a project to support the Revansh drop-in centre in Kazakhstan, which at the time of filing the application was facing the threat of closure.

The conference scientific committee of the 16th EFPC conference in Bergen invites submissions of abstracts ( for presentations related to the scope and purpose of the conference. Deadline is 1 of May 2021.

Abstract submissions for IAS 2021 – the 11th IAS Conference on HIV Science which will be held virtually from 18-21 July, 2021 – close in less than a month! Submit your research today to the global conference addressing cutting-edge HIV science, clinical innovation and global pandemic responses this July.